Tieni traccia delle ultime attività di insider trading Taysha Gene Therapies. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Taysha Gene Therapies.
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
A Taysha Gene Therapies Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori hanno riferito di aver venduto un totale di 111.55K azioni del valore di $317.90K, nel frattempo, gli addetti ai lavori hanno segnalare nessun acquisto negli ultimi 30 giorni.
Aug 22, 2025 | PRESIDENT AND HEAD R&D | -57.05K | $2.85 | -$162.60K | SELL | -4.67% | 1.17M | Aug 21 | ||
Aug 22, 2025 | CHIEF FINANCIAL OFFICER | -54.49K | $2.85 | -$155.30K | SELL | -4.39% | 1.19M | Aug 21 | ||
Jun 03, 2025 | — | 750.00K | $2.75 | $2.06M | BUY | 12.31% | 6.84M | May 30 | ||
Jul 01, 2024 | — | 1.33M | $2.25 | $3.00M | BUY | 27.56% | 6.17M | Jun 27 | ||
Nov 20, 2023 | 10% OWNER | 100.00K | $1.63 | $163.00K | BUY | 0.47% | 21.40M | Nov 17 | ||
Aug 25, 2023 | CHIEF FINANCIAL OFFICER | -33.00K | $2.33 | -$76.89K | SELL | -11.34% | 258.04K | Aug 24 | ||
Aug 16, 2023 | 10% OWNER | 16.47M | $0.90 | $14.82M | BUY | 340.40% | 21.30M | Aug 16 | ||
Aug 16, 2023 | DIRECTOR | 827.78K | $0.90 | $700.00K | BUY | 373.54% | 1.05M | Aug 16 | ||
Aug 16, 2023 | CHIEF EXECUTIVE OFFICER | 444.44K | $0.90 | $400.00K | BUY | 40.69% | 1.54M | Aug 16 | ||
Aug 16, 2023 | DIRECTOR | 111.11K | $0.90 | $100.00K | BUY | 3703.70% | 114.11K | Aug 16 | ||
Jul 14, 2023 | — | -85.87K | $0.71 | -$60.77K | SELL | -0.94% | 9.01M | Jul 12 - Jul 13 | ||
Jun 26, 2023 | 10% OWNER | -28.61K | $0.70 | -$20.12K | SELL | -0.31% | 9.10M | Jun 22 - Jun 23 | ||
Jun 22, 2023 | 10% OWNER | -434.62K | $0.71 | -$307.84K | SELL | -4.55% | 9.13M | Jun 20 - Jun 21 | ||
May 18, 2023 | PRESIDENT AND HEAD R&D | 5.00K | $0.68 | $3.40K | BUY | 17.11% | 34.23K | May 16 | ||
Nov 02, 2022 | DIRECTOR | 1.50M | $2.00 | $3.00M | BUY | 44.95% | 4.84M | Oct 31 | ||
Aug 24, 2022 | CHIEF FINANCIAL OFFICER | -3.33K | $3.47 | -$11.54K | SELL | -1.23% | 266.12K | Aug 23 | ||
Aug 22, 2022 | CHIEF FINANCIAL OFFICER | -28.68K | $3.70 | -$106.00K | SELL | -9.62% | 269.45K | Aug 18 - Aug 22 | ||
Jul 07, 2022 | CMO AND HEAD R&D | -12.86K | $3.70 | -$47.65K | SELL | -2.37% | 530.59K | Jul 05 - Jul 06 | ||
Jul 01, 2022 | CMO AND HEAD R&D | -50.14K | $3.65 | -$183.08K | SELL | -8.45% | 543.45K | Jun 29 - Jul 01 | ||
Feb 04, 2022 | DIRECTOR | 201.60K | $7.80 | $1.57M | BUY | 3.96% | 5.29M | Feb 02 - Feb 03 | ||
Feb 03, 2022 | DIRECTOR | 10.00K | $8.01 | $80.10K | BUY | 52.01% | 29.23K | Feb 02 | ||
Feb 03, 2022 | DIRECTOR | 3.00K | $7.78 | $23.34K | BUY | ∞ | 3.00K | Feb 02 | ||
Dec 08, 2021 | PRESIDENT AND CEO | 42.52K | $12.44 | $529.10K | BUY | 0.46% | 9.33M | Nov 23 | ||
Nov 29, 2021 | DIRECTOR | 2.20K | $13.19 | $29.04K | BUY | 0.11% | 2.05M | Nov 24 | ||
Nov 24, 2021 | DIRECTOR | 20.00K | $12.54 | $250.80K | BUY | 0.98% | 2.05M | Nov 23 | ||
Aug 20, 2021 | CHIEF FINANCIAL OFFICER | -33.00K | $16.88 | -$557.02K | SELL | -9.97% | 298.12K | Aug 18 - Aug 20 | ||
Jul 01, 2021 | CMO AND HEAD R&D | -79.00K | $22.63 | -$1.79M | SELL | -11.75% | 593.59K | Jun 29 - Jul 01 | ||
May 24, 2021 | DIRECTOR | 1.17K | $22.35 | $26.15K | BUY | 0.11% | 1.09M | May 20 | ||
May 17, 2021 | DIRECTOR | 12.00K | $20.98 | $251.76K | BUY | 0.59% | 2.03M | May 14 |
Sfoglia insider trading su tutte le azioni.